HUP9900449A2 - Gadolíniumkomplexek és kontrasztanyag-kompozíciók diagnosztikai leképzésekhez - Google Patents
Gadolíniumkomplexek és kontrasztanyag-kompozíciók diagnosztikai leképzésekhezInfo
- Publication number
- HUP9900449A2 HUP9900449A2 HU9900449A HUP9900449A HUP9900449A2 HU P9900449 A2 HUP9900449 A2 HU P9900449A2 HU 9900449 A HU9900449 A HU 9900449A HU P9900449 A HUP9900449 A HU P9900449A HU P9900449 A2 HUP9900449 A2 HU P9900449A2
- Authority
- HU
- Hungary
- Prior art keywords
- stone
- pipe powder
- general formula
- powder
- atom
- Prior art date
Links
- 238000002059 diagnostic imaging Methods 0.000 title abstract 2
- 239000002184 metal Substances 0.000 title 1
- 229920001308 poly(aminoacid) Polymers 0.000 title 1
- 239000000843 powder Substances 0.000 abstract 7
- 239000004575 stone Substances 0.000 abstract 5
- 229910052799 carbon Inorganic materials 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 3
- 239000011707 mineral Substances 0.000 abstract 3
- 239000002872 contrast media Substances 0.000 abstract 2
- 238000003384 imaging method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 238000004061 bleaching Methods 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001767 cationic compounds Chemical class 0.000 abstract 1
- 239000004568 cement Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000013007 heat curing Methods 0.000 abstract 1
- 229910001411 inorganic cation Inorganic materials 0.000 abstract 1
- 229910052740 iodine Chemical group 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 150000002892 organic cations Chemical class 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0442—Polymeric X-ray contrast-enhancing agent comprising a halogenated group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polyamides (AREA)
Abstract
A találmány pőliaminősavak gadőlíniűmkőmplexeire és diagnősztikaileképezésekhez alkalmas kőntrasztanyag-kőmpőzíciókra vőnatkőzik. Atalálmány szerinti gadőlínűmkőmplexek (I) általánős képletében Rjelentése (B) általánős képletű csőpőrt, ahől X jelentése brómatőmvagy jódatőm; R1 jelentése hidrőgénatőm, 1-3 szénatőmős alkilcsőpőrt,2-8 szénatőmős mőnőhidrőxi-alkil-csőpőrt vagy 2-8 szénatőmőspőlihidrőxi-alkil-csőpőrt; és R2 jelentése 2-8 szénatőmős mőnőhidrőxi-alkil-csőpőrt vagy 2-8 szénatőmős pőlihidrőxi-alkil-csőpőrt; illetveR1 jelentése hidrőgénatőm és R2 jelentése (A) általánős képletűcsőpőrt, ahől X jelentése a már megadőtt; R'1 és R'2 jelentése -egymástól függetlenül - az (A) általánős képletű csőpőrtőt kivévemegegyezik R1 és R2 jelentésével, azzal a megkötéssel, hőgy a -CO-NR1R2 vagy -CO-NR'1R'2 általánős képletű csőpőrt legalább kéthidrőxilcsőpőrtőt főglal magában; és M jelentése hidrőgénatőm, szerveskatiőn vagy szervetlen katiőn A találmány szerinti, mágnesesrezőnanciás és/vagy röntgensűgaras leképezéshez alkalmazhatókőntrasztanyag-kőmpőzíciók szőkásősan alkalmazőtt hőrdőzóanyagőkmellett (I) általánős képletű vegyületeket tartalmaznak farmakőlógiaiszempőntból elfőgadható bázissal képzett só főrmájában. A találmányszerinti kőntrasztanyag-kőmpőzíciókkal diagnősztikai célőkra sőkkkaljőbb leképezések valósíthatók meg, mint az eddig ismertkőntrasztanyagőkkal. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9507860A FR2736051B3 (fr) | 1995-06-29 | 1995-06-29 | Complexes metalliques de polyaminoacides, leur procede de preparation et leur utilisation en imagerie diagnostique |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9900449A2 true HUP9900449A2 (hu) | 1999-06-28 |
HUP9900449A3 HUP9900449A3 (en) | 2001-05-28 |
Family
ID=9480531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9900449A HUP9900449A3 (en) | 1995-06-29 | 1996-06-25 | Metal complexes of polyaminoacids, and their utilization in diagnostic imaging |
Country Status (21)
Country | Link |
---|---|
US (1) | US5886158A (hu) |
EP (1) | EP0835140B1 (hu) |
JP (1) | JPH11508550A (hu) |
KR (1) | KR19990028556A (hu) |
CN (1) | CN1074934C (hu) |
AT (1) | ATE207762T1 (hu) |
AU (1) | AU708180B2 (hu) |
BR (1) | BR9609519A (hu) |
CA (1) | CA2222697A1 (hu) |
CZ (1) | CZ414197A3 (hu) |
DE (1) | DE69616548T2 (hu) |
EA (1) | EA000378B1 (hu) |
FR (1) | FR2736051B3 (hu) |
HU (1) | HUP9900449A3 (hu) |
IL (1) | IL122621A0 (hu) |
NO (1) | NO976098L (hu) |
NZ (1) | NZ312720A (hu) |
PL (1) | PL325531A1 (hu) |
SK (1) | SK282197B6 (hu) |
TR (1) | TR199701716T1 (hu) |
WO (1) | WO1997001359A2 (hu) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2772025B1 (fr) | 1997-12-10 | 2000-03-03 | Guerbet Sa | Chelates metalliques de macrocycles polyaminocarboxyliques et leur application a l'imagerie par resonance magnetique |
IT1297035B1 (it) * | 1997-12-30 | 1999-08-03 | Bracco Spa | Derivati dell'acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico |
FR2793795B1 (fr) * | 1999-05-21 | 2001-08-03 | Guerbet Sa | Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale |
FR2794744B1 (fr) * | 1999-06-09 | 2001-09-21 | Guerbet Sa | Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale |
KR100309386B1 (ko) * | 1999-08-04 | 2001-09-26 | 이계안 | 파트타임 4륜구동차량의 자동절환식 차동장치 |
FR2836916B1 (fr) * | 2002-03-05 | 2004-06-11 | Guerbet Sa | Oligomeres de chelates de gadolinium, leur application comme produits de contraste en imagerie par resonance magnetique et leurs intermediaires de synthese |
DE10307759B3 (de) * | 2003-02-19 | 2004-11-18 | Schering Ag | Trimere makrocyclisch substituierte Benzolderivate, deren Herstellung und Verwendung als Kontrastmittel sowie diese enthaltende pharmazeutische Mittel |
FR2856689A1 (fr) * | 2003-06-25 | 2004-12-31 | Guerbet Sa | Composes specifiques a forte relaxivite |
US20060275217A1 (en) * | 2005-05-06 | 2006-12-07 | Caravan Peter D | Chemical exchange saturation transfer contrast agents |
KR101193686B1 (ko) * | 2005-08-29 | 2012-10-22 | 니혼앗짜쿠단시세이소 가부시키가이샤 | 전기 커넥터 및 액정 표시 장치 |
DE102007058220A1 (de) | 2007-12-03 | 2009-06-04 | Bayer Schering Pharma Aktiengesellschaft | Dimere macrocyclisch substituierte Benzolderivate |
US20090208421A1 (en) * | 2008-02-19 | 2009-08-20 | Dominique Meyer | Process for preparing a pharmaceutical formulation of contrast agents |
MX2014001623A (es) | 2011-08-10 | 2015-03-09 | Digna Biotech Sl | Uso de la cardiotofina-1 para el tratamiento de enfermedades renales. |
WO2017165841A1 (en) | 2016-03-25 | 2017-09-28 | Nanoprobes, Inc. | Iodine-based particles |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8916782D0 (en) * | 1989-07-21 | 1989-09-06 | Nycomed As | Compositions |
US5116599A (en) * | 1989-07-31 | 1992-05-26 | Johns Hopkins Univ. | Perfluoro-t-butyl-containing compounds for use in fluorine-19 nmr and/or mri |
US5324503A (en) * | 1992-02-06 | 1994-06-28 | Mallinckrodt Medical, Inc. | Iodo-phenylated chelates for x-ray contrast |
EP0703790B1 (en) * | 1993-06-02 | 2000-08-16 | BRACCO S.p.A. | Iodinated paramagnetic chelates, and their use as contrast agents |
-
1995
- 1995-06-29 FR FR9507860A patent/FR2736051B3/fr not_active Expired - Lifetime
-
1996
- 1996-06-25 DE DE69616548T patent/DE69616548T2/de not_active Expired - Lifetime
- 1996-06-25 AU AU64616/96A patent/AU708180B2/en not_active Ceased
- 1996-06-25 AT AT96924020T patent/ATE207762T1/de not_active IP Right Cessation
- 1996-06-25 PL PL96325531A patent/PL325531A1/xx unknown
- 1996-06-25 US US08/981,022 patent/US5886158A/en not_active Expired - Fee Related
- 1996-06-25 KR KR1019970709876A patent/KR19990028556A/ko not_active Application Discontinuation
- 1996-06-25 EP EP96924020A patent/EP0835140B1/fr not_active Expired - Lifetime
- 1996-06-25 SK SK1737-97A patent/SK282197B6/sk unknown
- 1996-06-25 EA EA199800101A patent/EA000378B1/ru not_active IP Right Cessation
- 1996-06-25 WO PCT/FR1996/000992 patent/WO1997001359A2/fr not_active Application Discontinuation
- 1996-06-25 CZ CZ974141A patent/CZ414197A3/cs unknown
- 1996-06-25 IL IL12262196A patent/IL122621A0/xx not_active IP Right Cessation
- 1996-06-25 HU HU9900449A patent/HUP9900449A3/hu unknown
- 1996-06-25 JP JP9504203A patent/JPH11508550A/ja active Pending
- 1996-06-25 CA CA002222697A patent/CA2222697A1/fr not_active Abandoned
- 1996-06-25 BR BR9609519A patent/BR9609519A/pt active Search and Examination
- 1996-06-25 CN CN96195154A patent/CN1074934C/zh not_active Expired - Fee Related
- 1996-06-25 TR TR97/01716T patent/TR199701716T1/xx unknown
- 1996-06-25 NZ NZ312720A patent/NZ312720A/en unknown
-
1997
- 1997-12-29 NO NO976098A patent/NO976098L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL325531A1 (en) | 1998-08-03 |
DE69616548D1 (de) | 2001-12-06 |
WO1997001359A3 (fr) | 1997-05-22 |
HUP9900449A3 (en) | 2001-05-28 |
EP0835140B1 (fr) | 2001-10-31 |
CN1074934C (zh) | 2001-11-21 |
FR2736051B3 (fr) | 1997-09-26 |
EA199800101A1 (ru) | 1998-08-27 |
CA2222697A1 (fr) | 1997-01-16 |
DE69616548T2 (de) | 2002-07-18 |
BR9609519A (pt) | 1999-02-23 |
AU6461696A (en) | 1997-01-30 |
EA000378B1 (ru) | 1999-06-24 |
WO1997001359A2 (fr) | 1997-01-16 |
IL122621A0 (en) | 1998-08-16 |
TR199701716T1 (xx) | 1998-04-21 |
SK173797A3 (en) | 1998-06-03 |
KR19990028556A (ko) | 1999-04-15 |
SK282197B6 (sk) | 2001-12-03 |
ATE207762T1 (de) | 2001-11-15 |
FR2736051A1 (fr) | 1997-01-03 |
AU708180B2 (en) | 1999-07-29 |
NO976098L (no) | 1998-02-27 |
CZ414197A3 (cs) | 1998-03-18 |
JPH11508550A (ja) | 1999-07-27 |
CN1189778A (zh) | 1998-08-05 |
MX9710380A (es) | 1998-07-31 |
US5886158A (en) | 1999-03-23 |
NO976098D0 (no) | 1997-12-29 |
EP0835140A2 (fr) | 1998-04-15 |
NZ312720A (en) | 1999-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9900449A2 (hu) | Gadolíniumkomplexek és kontrasztanyag-kompozíciók diagnosztikai leképzésekhez | |
ES532965A0 (es) | Procedimiento para la polimerizacion de un material polimerizable radicalica o cationicamente | |
ES2115298T3 (es) | Nuevos derivados de 1-fenil-3-dimetil-amino-propano, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
SE8302130L (sv) | Farmakologiskt aktiva bifosfonater, forfarande for deras framstellning och farmaceutiska kompositioner innehallande desamma | |
EP0250903A3 (en) | Diazabicycloû3,3,1¨ nonanes | |
PT855401E (pt) | Composicoes para contraste em ressonancia magnetica nuclear | |
FR2384805A1 (fr) | Sels de polyesters lineaires | |
SE7510196L (sv) | Sett att framstella nya 2,3-dihydro-1-bensotiepin-4-karboxylsyraamider | |
ES437996A1 (es) | Procedimiento de preparacion de derivados poliyodados del benceno. | |
ES2055637T3 (es) | Nuevos compuestos poli-yodados, procedimiento de preparacion, producto de contraste que los contiene. | |
JPS5610110A (en) | Acetyl salicylate salt preparation for injection | |
BR9407257A (pt) | Composto do tipo bis-naftalimida composição farmacêutica processo para tratamento de um tumor em mamifero uso do composto do tipo bis-naftalimida e processo para a preparação compostos do tipo bis-naftalimida | |
ES2134313T3 (es) | Utilizacion de derivados de pregnano para el tratamiento de tumores. | |
NO305960B1 (no) | Svovelholdige og tiosubstituerte fosfonatforbindelser, farmasoeytisk preparat omfattende en slik forbindelse samt anvendelse derav | |
MX9203928A (es) | Mono y bis alquilamino-antraciclinas y procedimiento para su preparacion. | |
ES466192A1 (es) | Procedimiento para la obtencion de derivados de la isoqui- noleina. | |
DK436580A (da) | Kavitationshaemmende frostsikre koele-henholdsvis varmeoverfoeringsvaesker | |
ES440723A1 (es) | Procedimiento para la produccion de nuevos compuestos orga- nicos. | |
ES453100A1 (es) | Metodo de preparar una cinamamida. | |
SE7708452L (sv) | Komposition innehallande en antrakinonforening | |
EP0627438A4 (en) | METHANDIPHOSPHONIC ACID DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF. | |
ES360862A1 (es) | Procedimiento para la preparacion de nuevos derivados de tiazepina. | |
GB1480231A (en) | Benzalicyclic carboxylic acid derivatives | |
ES378209A2 (es) | Procedimiento para la preparacion de nuevos 2- amino - 5 - nitro - triazoles sustituido en el grupo amino. | |
ES8107159A1 (es) | Un procedimiento para preparar sales de lisina y arginina del acido 5-(2,4-difluorofenil)-2-hidroxibenzoico |